ACM
Asymmetry Capital Management Portfolio holdings
AUM
$188M
This Quarter Return
+12.16%
1 Year Return
+45.88%
3 Year Return
+300.28%
5 Year Return
+633.15%
10 Year Return
–
AUM
$188M
AUM Growth
+$188M
(+13%)
Cap. Flow
+$23.3M
Cap. Flow
% of AUM
12.37%
Top 10 Holdings %
Top 10 Hldgs %
64.3%
Holding
38
New
9
Increased
8
Reduced
7
Closed
14
Top Buys
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$15.7M |
| 2 |
UnitedHealth
UNH
|
$13.5M |
| 3 |
AbbVie
ABBV
|
$12.8M |
| 4 |
IQVIA
IQV
|
$12.5M |
| 5 |
Centene
CNC
|
$12.2M |
Top Sells
| 1 |
Alkermes
ALKS
|
$11.5M |
| 2 |
Medtronic
MDT
|
$10.5M |
| 3 |
Insulet
PODD
|
$10.4M |
| 4 |
Hologic
HOLX
|
$10.3M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$10.2M |
Sector Composition
| 1 | Healthcare | 99.63% |
| 2 | Financials | 0.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Avalo Therapeutics
AVTX
$139M
| – | – |
-186
| Closed | -$1.17M |
|
27
AstraZeneca
AZN
$255B
| – | – |
-116,242
| Closed | -$6.98M |
|
28
Baxter International
BAX
$12.1B
| – | – |
-61,570
| Closed | -$4.95M |
|
|
29
Hologic
HOLX
$14.7B
| – | – |
-138,884
| Closed | -$10.3M |
|
30
Disc Medicine
IRON
$2.14B
| – | – |
-9,469
| Closed | -$1.15M |
|
31
Kymera Therapeutics
KYMR
$3.1B
| – | – |
-89,071
| Closed | -$5.23M |
|
32
Larimar Therapeutics
LRMR
$337M
| – | – |
-34,943
| Closed | -$403K |
|
|
33
Medtronic
MDT
$118B
| – | – |
-83,737
| Closed | -$10.5M |
|
|
34
Insulet
PODD
$24.2B
| – | – |
-36,732
| Closed | -$10.4M |
|
35
PTC Therapeutics
PTCT
$4.41B
| – | – |
-215,985
| Closed | -$8.04M |
|
36
Avidity Biosciences
RNA
$6.12B
| – | – |
-126,116
| Closed | -$3.11M |
|
|
SAGE
37
DELISTED
Sage Therapeutics
SAGE
| – | – |
-229,117
| Closed | -$10.2M |
|
|
ARNA
38
DELISTED
Arena Pharmaceuticals Inc
ARNA
| – | – |
-150,001
| Closed | -$8.93M |
|